In a Dec. 12 article about a class that was co-taught by Professor Uwe Reinhardt and visiting professor and former senator Bill Frist ’74, a quote from a student misrepresented Reinhardt’s views on drug-company profits. He has said in the class that while drug-company profits as a percent of sales revenue are high, that is a meaningless measure; these profits do not drive health-care costs because they make up only 1.2 percent of total national heath-care spending. More-over, Reinhardt has said, pharmaceutical companies must invest heavily in a protracted and risky process of research and development to bring each successful drug to market — an investment that must be recovered through drug prices.
Laurance Rockefeller ’32 was the grandson and not the son of oilman John D. Rockefeller, as was reported incorrectly in his profile in the Jan. 23 issue. He was the son of philanthropist John D. Rockefeller Jr.